Arcturus Therapeutics Holdings, Inc. (ARCT)
7.125
-0.18
(-2.40%)
USD |
NASDAQ |
Jun 08, 16:00
7.125
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Total Liabilities (Quarterly) : 54.05M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Oncotelic Therapeutics, Inc. | 131.74M |
| Enanta Pharmaceuticals, Inc. | 198.12M |
| Veracyte, Inc. | 91.99M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 245.41M |
| Shareholders Equity (Quarterly) | 191.36M |
| Debt to Equity Ratio | 0.1253 |
| Current Ratio | 6.310 |
| Net Debt Paydown Yield | 0.42% |